The Life Sciences Industry: Decision Making from Batch to Continuum
APRIL 5, 2017
In developed markets, governments are restricting the freedom to price new drugs. Technology is also playing spoilsport to the breakthrough party. Digital capabilities and big data is transforming everything from discovery to commercialization. PWC in its 18 th global CEO survey reports that 50% of Pharma CEOs were concerned about the speed of technological change, up from 32% in the previous year.